# US 2025/0002873 A1 · Retinoid production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0002873 A1
- Document ID: US20250002873A1
- Status: Published application
- Kind: A1
- Application number: 18/700,931
- Filed: 2022-10-19
- Published: 2025-01-02
- Earliest claimed: 2021-10-19
- Assignees: Dsm IP Assets B.V.
- Applicants: Dsm IP Assets B.V.
- Inventors: Valmik Kanubhai VYAS; Peter Louis HOUSTON; Jenna McMAHON; René Marcel DE JONG
- Web page: https://patentgrep.com/patent/US20250002873A1

## CPC

- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12P 23/00: Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing heterorings C12P17/00)
- A61K 31/07: Retinol compounds, e.g. vitamin A (retinoic acids A61K31/203)
- C12P 7/22: aromatic
- C12P 7/62: Carboxylic acid esters
- C12Y 101/01105: Retinol dehydrogenase (1.1.1.105)
- C12R 2001/73: Candida lipolytica
- C12R 2001/78: Hansenula
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention is related to bio-production of retinoids with improved purity profile, particularly bio-retinoids with a high percentage of retinyl acetate, wherein the flux towards retinol is increased and wherein the percentage of unwanted by-products such as dihydroretinoids or retinal is minimized to a range of below 10% by expressing retinol dehydrogenase (EC 1.1.1.105, RDH22) derived from Yarrowia lipolytica (Candida lipolytica) or Wickerhamomyces anomalus (Hanensula anomala).

## Claims

### Claim 1

A retinol-producing host cell expressing a retinol dehydrogenase 22 (RDH22) homolog with at least about 30% identity to a polynucleotide according to SEQ ID NO: 1 or 4, wherein the host cell has been transformed with said polynucleotide encoding said RDH22 homolog and wherein the percentage of dihydroretinoids in a mix of retinoids produced using said host cell under suitable culture conditions is less than about 10% based on total retinoids.

### Claim 2 (depends on 1)

The retinol-producing host cell according to claim 1, wherein said process furthermore comprises acetylation of retinol into retinyl acetate.

### Claim 3 (depends on 2)

The retinol-producing host cell according to claim 2, wherein the percentage of retinyl acetate in said mix is at least about 80% based on total retinoids.

### Claim 4 (depends on 1)

The retinol producing host cell according to claim 1, wherein the percentage of retinal in said mix is less than about 8% based on total retinoids.

### Claim 5 (depends on 4)

The retinol-producing host cell according to claim 4, wherein the percentage of retinal is reduced to less than about 1% based on total retinoids.

### Claim 6 (depends on 1)

The retinol producing host cell according to claim 1, wherein said mix of retinoids comprises trans and cis-isomers and wherein the percentage of trans-isomers is at least about 80% based on total cis and trans-isomers in said mix.

### Claim 7 (depends on 1)

The retinol-producing host cell according to claim 1, wherein the RDH22 homolog is obtained from Yarrowia or Wickerhamomyces.

### Claim 8 (depends on 1)

The retinol-producing host cell according to claim 1, furthermore expressing a retinol dehydrogenase 12 (RDH12) homolog.

### Claim 9 (depends on 1)

Process for the production of a retinoid-mix comprising cultivation of a retinol-producing host cell according to claim 1 under suitable culture conditions.

### Claim 10 (depends on 9)

Process according to claim 9, wherein said retinoid mix comprises dihydroretinal, dihydroretinol and dihydroretinyl acetate, retinol, retinal, retinyl acetate, and wherein the percentage of dihydroretinoids based on total retinoids is less than 10%.

### Claim 11 (depends on 9)

Process according to claim 9, wherein the host cell is cultivated in the presence of a lipophilic solvent.

### Claim 12 (depends on 11)

Process according to claim 11, wherein the retinoids are accumulated in the lipophilic solvent and optionally extracted from the lipophilic solvent.

### Claim 13 (depends on 11)

Process according to claim 11, wherein the lipophilic solvent is selected from isoparaffins including mixtures of alkanes, cycloparaffin, isoalkanes, cycloalkanes, or dodecanes.

### Claim 14 (depends on 9)

Process according to claim 9, wherein the host cell is a fungal host cell.
